$VSEE
VSEE HEALTH, INC. Stock $vsee

$vsee Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000155837024012936 Filed on September 23, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023 Q2
Revenue	$1.712M	$0.00	$0.00
YoY Change
Cost Of Revenue	$486.6K		$474.3K
YoY Change	2.6%
Gross Profit	$1.225M		$815.9K
YoY Change	50.13%
Gross Profit Margin	71.57%
Selling, General & Admin		$925.7K	$442.4K
YoY Change		-22.88%	-38.74%
% of Gross Profit			54.22%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.473K		$157.00
YoY Change	838.22%
% of Gross Profit	0.12%		0.02%
Operating Expenses	$2.408M	$925.7K	$442.4K
YoY Change	444.33%	-22.88%	-38.74%
Operating Profit	-$1.183M		-$442.4K
YoY Change	167.46%		-38.74%
Interest Expense		-$1.642M	$706.0K
YoY Change		-2461.59%	1025.96%
% of Operating Profit
Other Income/Expense, Net	-$1.420M	-$293.2K	$706.0K
YoY Change	-301.11%		1025.91%
Pretax Income	-$2.603M	-$2.861M	$263.6K
YoY Change	-1087.73%	153.03%	-139.96%
Income Tax	-$2.241M	$0.00	$0.00
% Of Pretax Income			0.0%
Net Earnings	-$330.0K	-$2.861M	$263.6K
YoY Change	-225.21%	131.68%	-139.96%
Net Earnings / Revenue	-19.28%
Basic Earnings Per Share	-$0.06		$0.06
Diluted Earnings Per Share	-$0.06	-$0.74	$0.06
COMMON SHARES
Basic Shares Outstanding	3.604M	3.584M	4.176M
Diluted Shares Outstanding	5.302M		4.180M

Balance Sheet

Concept	2024 Q2	2023 Q4	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$1.860K	$30.86K
YoY Change		-98.26%	-83.85%
Cash & Equivalents	$1.106M	$1.863K	$30.86K
Short-Term Investments
Other Short-Term Assets			$35.00K
YoY Change			-83.57%
Inventory
Prepaid Expenses			$35.00K
Receivables	$2.514M	$628.5K
Other Receivables	$785.9K
Total Short-Term Assets	$5.167M	$1.860K	$65.86K
YoY Change	7744.63%	-98.26%	-83.71%
LONG-TERM ASSETS
Property, Plant & Equipment	$883.3K	$3.657K
YoY Change
Goodwill	$59.90M
YoY Change
Intangibles	$12.10M
YoY Change
Long-Term Investments		$1.369M	$8.015M
YoY Change		-81.82%	-93.14%
Other Assets
YoY Change
Total Long-Term Assets	$73.82M	$1.369M	$8.015M
YoY Change	821.01%	-81.82%	-93.14%
TOTAL ASSETS
Total Short-Term Assets	$5.167M	$1.860K	$65.86K
Total Long-Term Assets	$73.82M	$1.369M	$8.015M
Total Assets	$78.99M	$1.371M	$8.081M
YoY Change	877.44%	-82.05%	-93.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$3.304M	$2.179M
YoY Change		75.15%	268.09%
Accrued Expenses		$96.36K	$31.65K
YoY Change		128.34%
Deferred Revenue	$1.023M	$802.5K
YoY Change
Short-Term Debt		$1.549M	$1.736M
YoY Change		125.55%	3855.47%
Long-Term Debt Due	$928.3K	$220.0K
YoY Change
Total Short-Term Liabilities	$22.88M	$7.984M	$5.044M
YoY Change	353.63%	142.27%	693.07%
LONG-TERM LIABILITIES
Long-Term Debt	$593.9K	$0.00	$0.00
YoY Change
Other Long-Term Liabilities		$4.370M	$4.370M
YoY Change		0.0%	0.0%
Total Long-Term Liabilities	$593.9K	$4.370M	$4.370M
YoY Change	-86.41%	0.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.88M	$7.984M	$5.044M
Total Long-Term Liabilities	$593.9K	$4.370M	$4.370M
Total Liabilities	$24.18M	$12.35M	$9.414M
YoY Change	156.83%	61.17%	88.05%
SHAREHOLDERS EQUITY
Retained Earnings	-$9.773M	-$12.82M	-$9.755M
YoY Change	0.19%	66.02%	115.74%
Common Stock	$1.481K	$350.00
YoY Change		0.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		-$10.98M	-$9.132M
YoY Change
Total Liabilities & Shareholders Equity	$78.99M	$1.371M	$8.081M
YoY Change	877.44%	-82.05%	-93.11%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023 Q2
OPERATING ACTIVITIES
Net Income	-$330.0K	-$2.861M	$263.6K
YoY Change	-225.21%	131.68%	-139.96%
Depreciation, Depletion And Amortization	$1.473K		$157.00
YoY Change	838.22%
Cash From Operating Activities		-$321.5K	-$250.1K
YoY Change		-52.46%	-21.52%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$6.808M	-$290.4K
YoY Change		-93.82%
Cash From Investing Activities		$6.808M	-$290.4K
YoY Change		-93.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-6.485M	555.0K
YoY Change		-94.07%
NET CHANGE
Cash From Operating Activities		-321.5K	-250.1K
Cash From Investing Activities		6.808M	-290.4K
Cash From Financing Activities		-6.485M	555.0K
Net Change In Cash		1.360K	14.54K
YoY Change		-97.81%	-104.56%
FREE CASH FLOW
Cash From Operating Activities		-$321.5K	-$250.1K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023Q4	us-gaap	Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2023Q4	us-gaap	Financing Receivable After Allowance For Credit Loss Noncurrent Related Party Type Extensible Enumeration FinancingReceivableAfterAllowanceForCreditLossNoncurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2023Q4	us-gaap	Other Liability Current Related Party Type Extensible Enumeration OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
	dei	Entity Central Index Key EntityCentralIndexKey	0001864531
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
CY2023Q2	vsee	Fair Value Liabilities Level1 To Level2 Transfers Amount1 FairValueLiabilitiesLevel1ToLevel2TransfersAmount1	0
CY2023Q2	vsee	Fair Value Liabilities Level1 To Level2 Transfers Amount1 FairValueLiabilitiesLevel1ToLevel2TransfersAmount1	0
CY2024Q2	vsee	Fair Value Liabilities Level1 To Level2 Transfers Amount1 FairValueLiabilitiesLevel1ToLevel2TransfersAmount1	0
CY2024Q2	vsee	Fair Value Liabilities Level1 To Level2 Transfers Amount1 FairValueLiabilitiesLevel1ToLevel2TransfersAmount1	0
CY2023Q2	vsee	Fair Value Liabilities Level2 To Level1 Transfers Amount1 FairValueLiabilitiesLevel2ToLevel1TransfersAmount1	0
CY2023Q2	vsee	Fair Value Liabilities Level2 To Level1 Transfers Amount1 FairValueLiabilitiesLevel2ToLevel1TransfersAmount1	0
CY2024Q2	vsee	Fair Value Liabilities Level2 To Level1 Transfers Amount1 FairValueLiabilitiesLevel2ToLevel1TransfersAmount1	0
CY2024Q2	vsee	Fair Value Liabilities Level2 To Level1 Transfers Amount1 FairValueLiabilitiesLevel2ToLevel1TransfersAmount1	0
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	0
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	0
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	0
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	0
CY2024Q2	us-gaap	Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q2	us-gaap	Financing Receivable After Allowance For Credit Loss Noncurrent Related Party Type Extensible Enumeration FinancingReceivableAfterAllowanceForCreditLossNoncurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q2	us-gaap	Other Liability Current Related Party Type Extensible Enumeration OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2024Q2	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#FinanceLeaseLiabilityCurrent
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#FinanceLeaseLiabilityNoncurrent
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y
	vsee	Future Receipts Sale Agreement Period Over Which Amount Is To Be Collected By Purchaser Weekly FutureReceiptsSaleAgreementPeriodOverWhichAmountIsToBeCollectedByPurchaserWeekly	P0Y
CY2024Q2	us-gaap	Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q2	us-gaap	Financing Receivable After Allowance For Credit Loss Noncurrent Related Party Type Extensible Enumeration FinancingReceivableAfterAllowanceForCreditLossNoncurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41015
	dei	Entity Registrant Name EntityRegistrantName	VSee Health, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-2970927
	dei	Entity Address Address Line1 EntityAddressAddressLine1	980 N Federal Hwy
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 304
	dei	Entity Address City Or Town EntityAddressCityOrTown	Boca Raton
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33432
	dei	City Area Code CityAreaCode	754
	dei	Local Phone Number LocalPhoneNumber	231-1688
	dei	Entity Information Former Legal Or Registered Name EntityInformationFormerLegalOrRegisteredName	DIGITAL HEALTH ACQUISITION CORP.
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1105971
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	118734
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1741238
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	32457
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2513855
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	628480
CY2024Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	785934
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	760789
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	79920
CY2024Q2	us-gaap	Assets Current AssetsCurrent	5166549
CY2023Q4	us-gaap	Assets Current AssetsCurrent	827134
CY2024Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	245500
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	691684
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12100000
CY2024Q2	us-gaap	Goodwill Goodwill	59900694
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	883323
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3657
CY2024Q2	us-gaap	Assets Assets	78987750
CY2023Q4	us-gaap	Assets Assets	830791
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6752985
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1824408
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1023492
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	802524
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	456858
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	338506
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	222910
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	507538
CY2024Q2	vsee	Factoring Payable Current FactoringPayableCurrent	348463
CY2024Q2	vsee	Business Combination Purchase Consideration Payable Current BusinessCombinationPurchaseConsiderationPayableCurrent	268038
CY2023Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount Current SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent	135000
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	600000
CY2024Q2	us-gaap	Senior Notes Current SeniorNotesCurrent	500000
CY2024Q2	us-gaap	Loans Payable Current LoansPayableCurrent	471651
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	323000
CY2024Q2	vsee	Line Of Credit And Note Payable Net Of Discount LineOfCreditAndNotePayableNetOfDiscount	928280
CY2023Q4	vsee	Line Of Credit And Note Payable Net Of Discount LineOfCreditAndNotePayableNetOfDiscount	220000
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	22879867
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4243438
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	593941
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	471507
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	231879
CY2024Q2	us-gaap	Liabilities Liabilities	24177194
CY2023Q4	us-gaap	Liabilities Liabilities	4243438
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	6158
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	6158
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	1
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14806820
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14806820
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4639643
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4639643
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	1481
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	464
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	64582130
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6027153
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9773056
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9114985
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-325279
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	54810556
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3412647
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	78987750
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	830791
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1711566
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1290223
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3207561
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2886491
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	486640
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	474287
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	872893
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1049609
CY2024Q2	us-gaap	Gross Profit GrossProfit	1224926
CY2023Q2	us-gaap	Gross Profit GrossProfit	815936
	us-gaap	Gross Profit GrossProfit	2334668
	us-gaap	Gross Profit GrossProfit	1836882
CY2024Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	918411
CY2023Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1084618
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1811988
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	2420170
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	509050
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	326386
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	660398
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	607639
CY2024Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	980807
CY2023Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	16059
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1007145
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	57345
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	2408268
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	1427063
	us-gaap	Operating Expenses OperatingExpenses	3479531
	us-gaap	Operating Expenses OperatingExpenses	3085154
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1183342
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-611127
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1144863
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1248272
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	349695
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	79860
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	359005
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	127262
CY2024Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	2
CY2023Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	3
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	2
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	19619
CY2024Q2	vsee	Fair Value Adjustment Of Financial Instruments FairValueAdjustmentOfFinancialInstruments	-548100
CY2023Q2	vsee	Fair Value Adjustment Of Financial Instruments FairValueAdjustmentOfFinancialInstruments	-88008
	vsee	Fair Value Adjustment Of Financial Instruments FairValueAdjustmentOfFinancialInstruments	-548100
	vsee	Fair Value Adjustment Of Financial Instruments FairValueAdjustmentOfFinancialInstruments	-114077
CY2024Q2	vsee	Gian Loss On Issuance Of Financial Instruments GianLossOnIssuanceOfFinancialInstruments	-1618234
	vsee	Gian Loss On Issuance Of Financial Instruments GianLossOnIssuanceOfFinancialInstruments	-1618234
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1419827
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	8151
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1429137
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6434
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2603169
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-602976
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2574000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1241838
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2241208
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-174395
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2241208
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-357238
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-361961
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-428581
	us-gaap	Profit Loss ProfitLoss	-332792
	us-gaap	Profit Loss ProfitLoss	-884600
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-31980
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3971
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-8738
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-329981
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-424610
	us-gaap	Net Income Loss NetIncomeLoss	-332792
	us-gaap	Net Income Loss NetIncomeLoss	-875862
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5302490
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5302490
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4639643
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4639643
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4971066
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4971066
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4639643
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4639643
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3412647
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-2811
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	31980
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3383478
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-31980
CY2024Q2	vsee	Stock Issued During Period Value Escrow Shares Released From Stock Payable StockIssuedDuringPeriodValueEscrowSharesReleasedFromStockPayable	127710
CY2024Q2	vsee	Stock Issued During Period Value Debt Settlement StockIssuedDuringPeriodValueDebtSettlement	155565
CY2024Q2	vsee	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	-17381444
CY2024Q2	vsee	Preferred Stock Issued During Period Value Settlement Of Debt As Part Of Consideration In Acquisition PreferredStockIssuedDuringPeriodValueSettlementOfDebtAsPartOfConsiderationInAcquisition	220000
CY2024Q2	vsee	Preferred Stock Issued During Period Value Settlement Of Underwriting Fee As Part Of Consideration In Acquisition PreferredStockIssuedDuringPeriodValueSettlementOfUnderwritingFeeAsPartOfConsiderationInAcquisition	4370000
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	31989
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-329981
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	54810556
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2033
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-451252
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-4767
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-458052
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-424610
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3971
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-886633
	us-gaap	Profit Loss ProfitLoss	-332792
	us-gaap	Profit Loss ProfitLoss	-884600
	vsee	Gian Loss On Issuance Of Financial Instruments GianLossOnIssuanceOfFinancialInstruments	-1618234
	vsee	Fair Value Adjustment Of Financial Instruments FairValueAdjustmentOfFinancialInstruments	-548100
	vsee	Fair Value Adjustment Of Financial Instruments FairValueAdjustmentOfFinancialInstruments	-114077
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	7000
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	74568
	vsee	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	3540
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31989
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2091
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	204
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	21428
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	22718
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2336506
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-357236
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-216774
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	107254
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	16208
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-51920
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1582393
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	931711
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	5526
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	220968
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-223631
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-210697
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	131034
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2594214
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-474643
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	45513
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2690
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16390
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2690
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2700000
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	200000
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	120000
	vsee	Repayment On Factoring Payable RepaymentOnFactoringPayable	10941
	vsee	Payment For Consideration Liability Financing Activities PaymentForConsiderationLiabilityFinancingActivities	1030
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	47800
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	365750
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3597841
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	320000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	987237
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-157333
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	118734
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	230664
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1105971
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	73331
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2772
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	18704806
	vsee	Stock Issued To Sponsor For Debt Settlement StockIssuedToSponsorForDebtSettlement	1268000
	vsee	Stock Issued To Underwriter StockIssuedToUnderwriter	4370000
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1310710
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14692820
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of the Company’s condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts stated in the condensed consolidated financial statements and accompanying notes. These judgments, estimates, and assumptions are used for, but not limited to, the determination of revenue recognition, allowance for credit losses, the fair value of the ELOC, , the Exchange Note, the Additional Bridge Note (as define below in the “<i style="font-style:italic;">Additional Bridge Financing</i>” section), the Quantum Convertible Note, and income taxes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company bases its estimates and judgments on historical experience and on various other assumptions that it believes are reasonable under the circumstances. However, future events are subject to change and best estimates and judgments routinely require adjustment. Actual results could differ from those estimates.</p>
CY2024Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	980807
CY2023Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	16059
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1007145
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	57345
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-329981
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-424610
	us-gaap	Net Income Loss NetIncomeLoss	-332792
	us-gaap	Net Income Loss NetIncomeLoss	-875862
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5302490
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5302490
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4639643
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4639643
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4971066
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4971066
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4639643
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4639643
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2024Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	2.00
CY2024Q2	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	2.00
CY2024Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0
CY2024Q2	vsee	Accounts Receivable Allowance For Credit Loss Increase From Acquisition AccountsReceivableAllowanceForCreditLossIncreaseFromAcquisition	1696553
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1741238
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	32457
CY2024Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	12227
CY2023Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4410
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	21428
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	22718
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	32457
	vsee	Accounts Receivable Allowance For Credit Loss Increase From Acquisition AccountsReceivableAllowanceForCreditLossIncreaseFromAcquisition	1696553
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	21428
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	32457
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	9200
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1741238
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	32457
	vsee	Fixed Asset Recognition Threshold FixedAssetRecognitionThreshold	1000
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2024Q2	us-gaap	Goodwill Goodwill	59900694
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2024Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	2701485
CY2023Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	2769241
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	5837245
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	6314200
CY2024Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-1791264
CY2023Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-1030910
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-2002771
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-2106741
CY2024Q2	vsee	Business Acquisition Pro Forma Weighted Average Shares Outstanding Basic BusinessAcquisitionProFormaWeightedAverageSharesOutstandingBasic	14694087
CY2023Q2	vsee	Business Acquisition Pro Forma Weighted Average Shares Outstanding Basic BusinessAcquisitionProFormaWeightedAverageSharesOutstandingBasic	14692820
	vsee	Business Acquisition Pro Forma Weighted Average Shares Outstanding Basic BusinessAcquisitionProFormaWeightedAverageSharesOutstandingBasic	14693450
	vsee	Business Acquisition Pro Forma Weighted Average Shares Outstanding Basic BusinessAcquisitionProFormaWeightedAverageSharesOutstandingBasic	14692820
CY2024Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.12
CY2023Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.07
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.14
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.14
CY2024Q2	vsee	Business Acquisition Pro Forma Amortization Of Intangible Assets BusinessAcquisitionProFormaAmortizationOfIntangibleAssets	-552500
CY2023Q2	vsee	Business Acquisition Pro Forma Amortization Of Intangible Assets BusinessAcquisitionProFormaAmortizationOfIntangibleAssets	-552500
	vsee	Business Acquisition Pro Forma Amortization Of Intangible Assets BusinessAcquisitionProFormaAmortizationOfIntangibleAssets	-1105000
	vsee	Business Acquisition Pro Forma Amortization Of Intangible Assets BusinessAcquisitionProFormaAmortizationOfIntangibleAssets	-1105000
CY2024Q2	vsee	Business Acquisition Pro Forma Transaction Expenses BusinessAcquisitionProFormaTransactionExpenses	182675
CY2023Q2	vsee	Business Acquisition Pro Forma Transaction Expenses BusinessAcquisitionProFormaTransactionExpenses	93059
	vsee	Business Acquisition Pro Forma Transaction Expenses BusinessAcquisitionProFormaTransactionExpenses	301013
	vsee	Business Acquisition Pro Forma Transaction Expenses BusinessAcquisitionProFormaTransactionExpenses	275114
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2024Q2	vsee	Estimated Value Of Shares And Options Granted EstimatedValueOfSharesAndOptionsGranted	60500000
CY2024Q2	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	292500
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14692820
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	1323362
CY2024Q2	vsee	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accrued Expenses BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses	4876314
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther	657659
CY2024Q2	vsee	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Exchange Notes Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesExchangeNotesPayable	6155925
CY2024Q2	vsee	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Line Of Credit BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLineOfCredit	694512
CY2024Q2	vsee	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Promissory Notes Payable Additional Bridge Loans BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesPromissoryNotesPayableAdditionalBridgeLoans	466646
CY2024Q2	vsee	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Notes Payable Related Party Sponsor BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedPartySponsor	350000
CY2024Q2	vsee	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Notes Payable Related Party Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedPartyOther	765000
CY2024Q2	vsee	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Deferred Offering Costs BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredOfferingCosts	4370000
CY2024Q2	vsee	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Notes Payable Extension Loan BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableExtensionLoan	335750
CY2024Q2	vsee	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Derivative Liability BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDerivativeLiability	33000
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	18704806
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	-17381444
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	889632
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4335
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6309
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	678
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	883323
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3657
CY2024Q2	us-gaap	Depreciation Depreciation	1473
CY2023Q2	us-gaap	Depreciation Depreciation	157
	us-gaap	Depreciation Depreciation	2091
	us-gaap	Depreciation Depreciation	204
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	3540
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	3540
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0
CY2024Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P3Y6M
	us-gaap	Operating Lease Expense OperatingLeaseExpense	3733
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	3733
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	199560
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	248520
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	251440
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	135400
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	82880
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	917800
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	223383
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	694417
CY2024Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	3733
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	3733
	us-gaap	Operating Lease Cost OperatingLeaseCost	3733
	us-gaap	Operating Lease Expense OperatingLeaseExpense	3733
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y6M
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.182
CY2024Q2	vsee	Lessee Finance Lease Number Of Leases LesseeFinanceLeaseNumberOfLeases	3
	vsee	Lessee Finance Lease Monthly Payments LesseeFinanceLeaseMonthlyPayments	20313
CY2024Q2	us-gaap	Lessee Finance Lease Discount Rate LesseeFinanceLeaseDiscountRate	0.193
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	736624
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	3540
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	733084
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	739417
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	507538
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	231879
CY2024Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	449683
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	243758
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	136485
CY2024Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	829926
CY2024Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	90509
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	739417
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0
CY2024Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	3540
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	559
	vsee	Finance Lease Total Expense FinanceLeaseTotalExpense	4099
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	3540
CY2024Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	559
CY2024Q2	vsee	Finance Lease Total Expense FinanceLeaseTotalExpense	4099
CY2024Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y1M6D
CY2024Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.193
	vsee	Future Receipts Sale Agreement Interest Rate FutureReceiptsSaleAgreementInterestRate	0
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	2428880
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	220000
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	928280
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	220000
CY2024Q2	vsee	Long Term Debt Fair Value Adjustments LongTermDebtFairValueAdjustments	906659
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	593941
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	928280
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	4567
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	26534
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	37720
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	39008
CY2024Q2	vsee	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	1392771
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	2428880
CY2023Q4	vsee	Debt Instrument Convertible Maximum Reset Of Conversion Price DebtInstrumentConvertibleMaximumResetOfConversionPrice	2.00
CY2023Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	10.00
CY2023Q4	vsee	Deferred Underwriting Fee DeferredUnderwritingFee	4370000
CY2023Q3	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount Current SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent	135000
CY2023Q3	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount Current SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent	135000
CY2024Q2	vsee	Gain Loss On Debt Conversion GainLossOnDebtConversion	20565
	us-gaap	Interest Income Financing Receivable Before Allowance For Credit Loss InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss	0
CY2024Q2	us-gaap	Interest Income Financing Receivable Before Allowance For Credit Loss InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss	0
CY2024Q2	us-gaap	Litigation Reserve Current LitigationReserveCurrent	0
CY2023Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	0
CY2024Q2	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	1049985
CY2024Q2	vsee	Purchase Commitment Adjustments And Payments Made PurchaseCommitmentAdjustmentsAndPaymentsMade	946152
CY2023Q4	vsee	Purchase Commitment Adjustments And Payments Made PurchaseCommitmentAdjustmentsAndPaymentsMade	639752
CY2024Q2	us-gaap	Purchase Obligation PurchaseObligation	103833
CY2023Q4	us-gaap	Purchase Obligation PurchaseObligation	410233
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2152167
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2463599
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2574000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1241838
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	540540
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	259956
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.6607
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.088
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1700668
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	97282
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2241208
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-357238
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2241208
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2241208
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.8707
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-174395
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-357238
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.298
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2024Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
	vsee	Threshold Ownership Percentage Eligible To Vote ThresholdOwnershipPercentageEligibleToVote	0.0499
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	vsee	Conversion Of Stock Equivalent Common Stock Shares Upon Conversion ConversionOfStockEquivalentCommonStockSharesUponConversion	12165889
CY2024Q2	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	4879067
CY2024Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.40
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14806820
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4639643
	vsee	Common Stock Number Of Votes Per Share CommonStockNumberOfVotesPerShare	1
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	803646
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	12.11
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	803646
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.11
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	629344
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	12.11
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	803646
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.11
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y11M26D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	629344
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	12.11
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P9Y11M26D
CY2024Q2	us-gaap	Share Price SharePrice	12.11
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	12.11
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.0500
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0446
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1394222
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	5034045
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31989
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31989
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3207561
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2886491
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1144863
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1248272
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1144863
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1248272
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	359005
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	127262
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	2
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	19619
	vsee	Fair Value Adjustment Of Financial Instruments FairValueAdjustmentOfFinancialInstruments	-548100
	vsee	Fair Value Adjustment Of Financial Instruments FairValueAdjustmentOfFinancialInstruments	-114077
	vsee	Gian Loss On Issuance Of Financial Instruments GianLossOnIssuanceOfFinancialInstruments	-1618234
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1429137
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6434
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2574000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1241838
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2241208
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-357238
	us-gaap	Profit Loss ProfitLoss	-332792
	us-gaap	Profit Loss ProfitLoss	-884600
CY2024Q2	us-gaap	Assets Assets	78987750
CY2023Q4	us-gaap	Assets Assets	830791
CY2024Q2	us-gaap	Goodwill Goodwill	59900694
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2091
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	204
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	45513
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	2690
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	359005
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	127262
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	7350083
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	4618234
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	-33000
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-535665
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	11399652
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001558370-24-012936-index-headers.html	Edgar Link	pending
0001558370-24-012936-index.html	Edgar Link	pending
0001558370-24-012936.txt	Edgar Link	pending
0001558370-24-012936-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vsee-20240630.xsd	Edgar Link	pending
vsee-20240630x10q.htm	Edgar Link	pending
vsee-20240630xex31d1.htm	Edgar Link	pending
vsee-20240630xex31d2.htm	Edgar Link	pending
vsee-20240630xex32d1.htm	Edgar Link	pending
vsee-20240630x10q_htm.xml	Edgar Link	completed
vsee-20240630_cal.xml	Edgar Link	unprocessable
vsee-20240630_lab.xml	Edgar Link	unprocessable
vsee-20240630_pre.xml	Edgar Link	unprocessable
vsee-20240630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VSEE
VSEE HEALTH, INC. Stock $vsee

2024 Q2 Form 10-Q Financial Statement

#000155837024012936 Filed on September 23, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VSEE VSEE HEALTH, INC. Stock $vsee

2024 Q2 Form 10-Q Financial Statement

#000155837024012936 Filed on September 23, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VSEE
VSEE HEALTH, INC. Stock $vsee